Scholtz & Company, LLC Abbott Laboratories Transaction History
Scholtz & Company, LLC
- $203 Million
- Q4 2024
A detailed history of Scholtz & Company, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Scholtz & Company, LLC holds 47,461 shares of ABT stock, worth $6.27 Million. This represents 2.64% of its overall portfolio holdings.
Number of Shares
47,461
Previous 41,559
14.2%
Holding current value
$6.27 Million
Previous $4.74 Million
13.3%
% of portfolio
2.64%
Previous 2.29%
Shares
26 transactions
Others Institutions Holding ABT
# of Institutions
3,352Shares Held
1.36BCall Options Held
10.6MPut Options Held
8.73M-
Vanguard Group Inc Valley Forge, PA169MShares$22.3 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY131MShares$17.3 Billion0.31% of portfolio
-
State Street Corp Boston, MA77.2MShares$10.2 Billion0.35% of portfolio
-
Capital International Investors Los Angeles, CA68MShares$8.98 Billion1.51% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.1MShares$7.15 Billion1.31% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $231B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...